
GO biological process complete	Homo sapiens - REFLIST (20851)	upload_1 (260)	upload_1 (expected)	upload_1 (over/under)	upload_1 (fold Enrichment)	upload_1 (raw P-value)	upload_1 (FDR)
extracellular structure organization (GO:0043062)	362	42	4.51	+	9.30	1.12E-26	8.92E-23
extracellular matrix organization (GO:0030198)	361	42	4.50	+	9.33	1.01E-26	1.62E-22
multicellular organism development (GO:0007275)	5086	143	63.42	+	2.25	1.24E-25	6.61E-22
anatomical structure development (GO:0048856)	5478	147	68.31	+	2.15	2.50E-24	9.97E-21
developmental process (GO:0032502)	5935	153	74.01	+	2.07	4.87E-24	1.55E-20
system development (GO:0048731)	4490	128	55.99	+	2.29	1.46E-22	3.90E-19
anatomical structure morphogenesis (GO:0009653)	2189	86	27.30	+	3.15	2.11E-22	4.80E-19
multicellular organismal process (GO:0032501)	7109	164	88.65	+	1.85	4.45E-21	8.88E-18
biological adhesion (GO:0022610)	945	53	11.78	+	4.50	9.98E-20	1.77E-16
cell adhesion (GO:0007155)	939	52	11.71	+	4.44	3.97E-19	6.34E-16
animal organ development (GO:0048513)	3242	99	40.43	+	2.45	3.40E-18	4.93E-15
regulation of developmental process (GO:0050793)	2663	85	33.21	+	2.56	1.36E-16	1.81E-13
tissue development (GO:0009888)	1774	66	22.12	+	2.98	9.90E-16	1.22E-12
regulation of cellular component movement (GO:0051270)	1025	49	12.78	+	3.83	1.32E-15	1.51E-12
cellular developmental process (GO:0048869)	3815	103	47.57	+	2.17	1.75E-15	1.86E-12
regulation of cell migration (GO:0030334)	877	44	10.94	+	4.02	9.23E-15	9.21E-12
circulatory system development (GO:0072359)	880	44	10.97	+	4.01	1.04E-14	9.73E-12
cell differentiation (GO:0030154)	3761	100	46.90	+	2.13	1.88E-14	1.67E-11
regulation of multicellular organismal process (GO:0051239)	3237	91	40.36	+	2.25	2.43E-14	2.04E-11
regulation of cell motility (GO:2000145)	940	44	11.72	+	3.75	9.40E-14	6.82E-11
regulation of locomotion (GO:0040012)	980	45	12.22	+	3.68	9.01E-14	6.85E-11
positive regulation of cell migration (GO:0030335)	525	33	6.55	+	5.04	8.66E-14	6.91E-11
regulation of multicellular organismal development (GO:2000026)	2099	68	26.17	+	2.60	2.25E-13	1.56E-10
positive regulation of cell motility (GO:2000147)	550	33	6.86	+	4.81	2.94E-13	1.95E-10
vasculature development (GO:0001944)	528	32	6.58	+	4.86	5.37E-13	3.43E-10
positive regulation of locomotion (GO:0040017)	565	33	7.05	+	4.68	5.92E-13	3.63E-10
positive regulation of cellular component movement (GO:0051272)	566	33	7.06	+	4.68	6.20E-13	3.66E-10
cardiovascular system development (GO:0072358)	537	32	6.70	+	4.78	8.24E-13	4.70E-10
blood vessel development (GO:0001568)	505	31	6.30	+	4.92	9.32E-13	5.13E-10
animal organ morphogenesis (GO:0009887)	968	43	12.07	+	3.56	1.01E-12	5.35E-10
tube development (GO:0035295)	863	40	10.76	+	3.72	1.96E-12	1.01E-09
positive regulation of biological process (GO:0048518)	6306	133	78.63	+	1.69	3.34E-12	1.67E-09
ossification (GO:0001503)	265	22	3.30	+	6.66	1.02E-11	4.66E-09
response to endogenous stimulus (GO:0009719)	1458	52	18.18	+	2.86	1.01E-11	4.74E-09
response to oxygen-containing compound (GO:1901700)	1604	55	20.00	+	2.75	9.82E-12	4.75E-09
skeletal system development (GO:0001501)	489	29	6.10	+	4.76	1.18E-11	5.21E-09
regulation of cell differentiation (GO:0045595)	1876	60	23.39	+	2.56	1.46E-11	6.31E-09
response to wounding (GO:0009611)	533	30	6.65	+	4.51	1.73E-11	7.08E-09
positive regulation of cellular process (GO:0048522)	5737	123	71.54	+	1.72	1.71E-11	7.18E-09
movement of cell or subcellular component (GO:0006928)	1584	54	19.75	+	2.73	1.96E-11	7.83E-09
neurogenesis (GO:0022008)	1686	56	21.02	+	2.66	2.04E-11	7.93E-09
regulation of anatomical structure morphogenesis (GO:0022603)	1112	44	13.87	+	3.17	2.14E-11	8.14E-09
cellular component organization (GO:0016043)	5658	121	70.55	+	1.72	3.72E-11	1.38E-08
regulation of signal transduction (GO:0009966)	3147	82	39.24	+	2.09	4.61E-11	1.64E-08
response to organic substance (GO:0010033)	3040	80	37.91	+	2.11	4.55E-11	1.65E-08
cellular response to endogenous stimulus (GO:0071495)	1187	45	14.80	+	3.04	4.78E-11	1.66E-08
locomotion (GO:0040011)	1337	48	16.67	+	2.88	5.94E-11	2.02E-08
regulation of signaling (GO:0023051)	3664	90	45.69	+	1.97	7.62E-11	2.53E-08
response to stimulus (GO:0050896)	8523	159	106.28	+	1.50	8.49E-11	2.77E-08
positive regulation of developmental process (GO:0051094)	1402	49	17.48	+	2.80	8.91E-11	2.84E-08
regulation of cell communication (GO:0010646)	3625	89	45.20	+	1.97	1.12E-10	3.51E-08
regulation of cell population proliferation (GO:0042127)	1668	54	20.80	+	2.60	1.28E-10	3.93E-08
Unclassified (UNCLASSIFIED)	2939	6	36.65	-	.16	1.81E-10	5.35E-08
biological_process (GO:0008150)	17912	254	223.35	+	1.14	1.81E-10	5.45E-08
supramolecular fiber organization (GO:0097435)	497	27	6.20	+	4.36	4.00E-10	1.16E-07
regulation of cellular component organization (GO:0051128)	2432	67	30.33	+	2.21	4.44E-10	1.27E-07
cellular component organization or biogenesis (GO:0071840)	5878	121	73.30	+	1.65	4.52E-10	1.27E-07
cellular response to organic substance (GO:0071310)	2378	66	29.65	+	2.23	5.01E-10	1.38E-07
positive regulation of multicellular organismal process (GO:0051240)	1788	55	22.30	+	2.47	5.63E-10	1.52E-07
wound healing (GO:0042060)	435	25	5.42	+	4.61	6.20E-10	1.65E-07
regulation of cell-substrate adhesion (GO:0010810)	214	18	2.67	+	6.75	6.79E-10	1.78E-07
cellular process (GO:0009987)	15430	233	192.40	+	1.21	7.63E-10	1.96E-07
regulation of response to stimulus (GO:0048583)	4371	98	54.50	+	1.80	8.90E-10	2.26E-07
anatomical structure formation involved in morphogenesis (GO:0048646)	897	36	11.19	+	3.22	1.25E-09	3.11E-07
negative regulation of cellular process (GO:0048523)	4873	105	60.76	+	1.73	1.53E-09	3.75E-07
generation of neurons (GO:0048699)	1582	50	19.73	+	2.53	2.30E-09	5.57E-07
tube morphogenesis (GO:0035239)	667	30	8.32	+	3.61	2.86E-09	6.82E-07
cellular response to oxygen-containing compound (GO:1901701)	1073	39	13.38	+	2.91	3.50E-09	8.23E-07
regulation of cell adhesion (GO:0030155)	720	31	8.98	+	3.45	4.11E-09	9.50E-07
cellular response to amino acid stimulus (GO:0071230)	71	11	.89	+	12.42	5.18E-09	1.18E-06
negative regulation of multicellular organismal process (GO:0051241)	1235	42	15.40	+	2.73	5.33E-09	1.20E-06
cell development (GO:0048468)	1644	50	20.50	+	2.44	5.79E-09	1.28E-06
blood vessel morphogenesis (GO:0048514)	415	23	5.17	+	4.44	5.96E-09	1.29E-06
cellular response to chemical stimulus (GO:0070887)	2941	73	36.67	+	1.99	5.91E-09	1.29E-06
positive regulation of cell differentiation (GO:0045597)	1005	37	12.53	+	2.95	6.71E-09	1.43E-06
positive regulation of response to stimulus (GO:0048584)	2414	64	30.10	+	2.13	8.25E-09	1.73E-06
nervous system development (GO:0007399)	2422	64	30.20	+	2.12	8.65E-09	1.79E-06
angiogenesis (GO:0001525)	321	20	4.00	+	5.00	9.69E-09	1.98E-06
response to chemical (GO:0042221)	4423	96	55.15	+	1.74	1.11E-08	2.25E-06
cellular response to acid chemical (GO:0071229)	78	11	.97	+	11.31	1.25E-08	2.50E-06
cellular response to stimulus (GO:0051716)	6610	127	82.42	+	1.54	1.31E-08	2.59E-06
tissue morphogenesis (GO:0048729)	550	26	6.86	+	3.79	1.34E-08	2.61E-06
proteoglycan biosynthetic process (GO:0030166)	61	10	.76	+	13.15	1.61E-08	3.10E-06
signal transduction (GO:0007165)	4950	103	61.72	+	1.67	1.82E-08	3.46E-06
connective tissue development (GO:0061448)	209	16	2.61	+	6.14	2.13E-08	3.87E-06
regulation of smooth muscle cell migration (GO:0014910)	63	10	.79	+	12.73	2.12E-08	3.90E-06
cell motility (GO:0048870)	1100	38	13.72	+	2.77	2.12E-08	3.94E-06
localization of cell (GO:0051674)	1100	38	13.72	+	2.77	2.12E-08	3.98E-06
enzyme linked receptor protein signaling pathway (GO:0007167)	733	30	9.14	+	3.28	2.23E-08	4.00E-06
negative regulation of biological process (GO:0048519)	5530	111	68.96	+	1.61	2.62E-08	4.59E-06
response to stress (GO:0006950)	3654	83	45.56	+	1.82	2.61E-08	4.63E-06
collagen fibril organization (GO:0030199)	48	9	.60	+	15.04	3.05E-08	5.29E-06
regulation of cell development (GO:0060284)	975	35	12.16	+	2.88	3.30E-08	5.66E-06
embryo development (GO:0009790)	1027	36	12.81	+	2.81	3.67E-08	6.23E-06
positive regulation of macromolecule metabolic process (GO:0010604)	3621	82	45.15	+	1.82	3.78E-08	6.28E-06
negative regulation of developmental process (GO:0051093)	981	35	12.23	+	2.86	3.82E-08	6.28E-06
positive regulation of signaling (GO:0023056)	1908	53	23.79	+	2.23	3.76E-08	6.33E-06
renal system development (GO:0072001)	283	18	3.53	+	5.10	4.05E-08	6.60E-06
embryonic morphogenesis (GO:0048598)	583	26	7.27	+	3.58	4.11E-08	6.62E-06
regulation of smooth muscle cell proliferation (GO:0048660)	137	13	1.71	+	7.61	4.55E-08	7.27E-06
regulation of neuron differentiation (GO:0045664)	676	28	8.43	+	3.32	5.36E-08	8.47E-06
response to oxidative stress (GO:0006979)	395	21	4.93	+	4.26	5.50E-08	8.61E-06
positive regulation of fibroblast proliferation (GO:0048146)	52	9	.65	+	13.88	5.63E-08	8.73E-06
positive regulation of signal transduction (GO:0009967)	1661	48	20.71	+	2.32	6.12E-08	9.31E-06
signaling (GO:0023052)	5322	107	66.36	+	1.61	6.07E-08	9.32E-06
cell communication (GO:0007154)	5413	108	67.50	+	1.60	7.22E-08	1.09E-05
regulation of cellular process (GO:0050794)	11160	182	139.16	+	1.31	8.30E-08	1.24E-05
heart development (GO:0007507)	525	24	6.55	+	3.67	9.07E-08	1.34E-05
cell migration (GO:0016477)	972	34	12.12	+	2.81	9.61E-08	1.41E-05
eye development (GO:0001654)	373	20	4.65	+	4.30	1.01E-07	1.47E-05
positive regulation of cell communication (GO:0010647)	1900	52	23.69	+	2.19	1.10E-07	1.58E-05
positive regulation of smooth muscle cell migration (GO:0014911)	40	8	.50	+	16.04	1.17E-07	1.67E-05
visual system development (GO:0150063)	377	20	4.70	+	4.25	1.19E-07	1.68E-05
sensory organ development (GO:0007423)	576	25	7.18	+	3.48	1.25E-07	1.73E-05
positive regulation of cell population proliferation (GO:0008284)	935	33	11.66	+	2.83	1.24E-07	1.74E-05
kidney development (GO:0001822)	273	17	3.40	+	4.99	1.30E-07	1.77E-05
chondroitin sulfate biosynthetic process (GO:0030206)	26	7	.32	+	21.59	1.29E-07	1.77E-05
regulation of neurogenesis (GO:0050767)	845	31	10.54	+	2.94	1.37E-07	1.85E-05
glycosaminoglycan biosynthetic process (GO:0006024)	101	11	1.26	+	8.73	1.40E-07	1.88E-05
sensory system development (GO:0048880)	383	20	4.78	+	4.19	1.52E-07	2.02E-05
osteoblast differentiation (GO:0001649)	127	12	1.58	+	7.58	1.58E-07	2.08E-05
regulation of nervous system development (GO:0051960)	959	33	11.96	+	2.76	2.17E-07	2.84E-05
urogenital system development (GO:0001655)	319	18	3.98	+	4.53	2.21E-07	2.86E-05
positive regulation of metabolic process (GO:0009893)	3920	84	48.88	+	1.72	2.52E-07	3.24E-05
regulation of localization (GO:0032879)	2846	67	35.49	+	1.89	2.62E-07	3.32E-05
aminoglycan biosynthetic process (GO:0006023)	108	11	1.35	+	8.17	2.61E-07	3.34E-05
regulation of protein phosphorylation (GO:0001932)	1461	43	18.22	+	2.36	2.74E-07	3.44E-05
regulation of biological process (GO:0050789)	11714	187	146.07	+	1.28	2.78E-07	3.47E-05
regulation of neuron projection development (GO:0010975)	519	23	6.47	+	3.55	2.88E-07	3.56E-05
regulation of plasma membrane bounded cell projection organization (GO:0120035)	696	27	8.68	+	3.11	3.29E-07	4.04E-05
response to acid chemical (GO:0001101)	137	12	1.71	+	7.02	3.37E-07	4.11E-05
chondroitin sulfate proteoglycan biosynthetic process (GO:0050650)	31	7	.39	+	18.11	3.61E-07	4.37E-05
proteoglycan metabolic process (GO:0006029)	88	10	1.10	+	9.11	3.65E-07	4.39E-05
positive regulation of smooth muscle cell proliferation (GO:0048661)	89	10	1.11	+	9.01	4.02E-07	4.79E-05
regulation of cell projection organization (GO:0031344)	705	27	8.79	+	3.07	4.19E-07	4.96E-05
cell surface receptor signaling pathway (GO:0007166)	2519	61	31.41	+	1.94	4.57E-07	5.37E-05
neuron differentiation (GO:0030182)	1045	34	13.03	+	2.61	4.90E-07	5.71E-05
positive regulation of nitrogen compound metabolic process (GO:0051173)	3274	73	40.82	+	1.79	5.13E-07	5.93E-05
response to amino acid (GO:0043200)	118	11	1.47	+	7.48	5.91E-07	6.79E-05
cellular response to growth factor stimulus (GO:0071363)	502	22	6.26	+	3.51	6.31E-07	7.19E-05
response to hydrogen peroxide (GO:0042542)	119	11	1.48	+	7.41	6.39E-07	7.24E-05
regulation of phosphorylation (GO:0042325)	1631	45	20.34	+	2.21	6.61E-07	7.44E-05
regulation of cell morphogenesis (GO:0022604)	509	22	6.35	+	3.47	7.87E-07	8.78E-05
central nervous system development (GO:0007417)	1019	33	12.71	+	2.60	8.11E-07	9.00E-05
cell-cell adhesion (GO:0098609)	511	22	6.37	+	3.45	8.37E-07	9.22E-05
regulation of intracellular signal transduction (GO:1902531)	1820	48	22.69	+	2.12	8.59E-07	9.40E-05
positive regulation of phosphate metabolic process (GO:0045937)	1160	36	14.46	+	2.49	8.85E-07	9.49E-05
positive regulation of phosphorus metabolic process (GO:0010562)	1160	36	14.46	+	2.49	8.85E-07	9.55E-05
cellular response to transforming growth factor beta stimulus (GO:0071560)	151	12	1.88	+	6.37	8.85E-07	9.61E-05
glycosaminoglycan metabolic process (GO:0030203)	153	12	1.91	+	6.29	1.01E-06	1.07E-04
positive regulation of cell-substrate adhesion (GO:0010811)	126	11	1.57	+	7.00	1.08E-06	1.14E-04
protein metabolic process (GO:0019538)	4396	89	54.82	+	1.62	1.21E-06	1.27E-04
response to transforming growth factor beta (GO:0071559)	158	12	1.97	+	6.09	1.38E-06	1.44E-04
regulation of phosphorus metabolic process (GO:0051174)	1829	48	22.81	+	2.10	1.43E-06	1.47E-04
regulation of phosphate metabolic process (GO:0019220)	1828	48	22.79	+	2.11	1.42E-06	1.47E-04
regulation of actin filament-based process (GO:0032970)	405	19	5.05	+	3.76	1.45E-06	1.49E-04
response to hormone (GO:0009725)	850	29	10.60	+	2.74	1.48E-06	1.51E-04
embryonic skeletal system development (GO:0048706)	131	11	1.63	+	6.73	1.54E-06	1.55E-04
response to growth factor (GO:0070848)	531	22	6.62	+	3.32	1.54E-06	1.55E-04
chondroitin sulfate metabolic process (GO:0030204)	40	7	.50	+	14.03	1.64E-06	1.63E-04
positive regulation of protein phosphorylation (GO:0001934)	1012	32	12.62	+	2.54	1.98E-06	1.96E-04
regulation of fibroblast proliferation (GO:0048145)	83	9	1.03	+	8.70	2.02E-06	1.99E-04
response to reactive oxygen species (GO:0000302)	196	13	2.44	+	5.32	2.08E-06	2.04E-04
negative regulation of cell death (GO:0060548)	1016	32	12.67	+	2.53	2.15E-06	2.09E-04
platelet activation (GO:0030168)	137	11	1.71	+	6.44	2.31E-06	2.24E-04
aminoglycan metabolic process (GO:0006022)	167	12	2.08	+	5.76	2.38E-06	2.29E-04
energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988)	5	4	.06	+	64.16	2.70E-06	2.55E-04
electron transport coupled proton transport (GO:0015990)	5	4	.06	+	64.16	2.70E-06	2.56E-04
developmental growth (GO:0048589)	383	18	4.78	+	3.77	2.70E-06	2.58E-04
positive regulation of molecular function (GO:0044093)	1835	47	22.88	+	2.05	2.78E-06	2.61E-04
regulation of protein metabolic process (GO:0051246)	2851	64	35.55	+	1.80	2.93E-06	2.74E-04
biological regulation (GO:0065007)	12390	191	154.50	+	1.24	3.03E-06	2.81E-04
mitochondrial ATP synthesis coupled electron transport (GO:0042775)	88	9	1.10	+	8.20	3.16E-06	2.91E-04
metabolic process (GO:0008152)	8585	145	107.05	+	1.35	3.22E-06	2.95E-04
phosphorylation (GO:0016310)	1285	37	16.02	+	2.31	3.34E-06	3.01E-04
growth (GO:0040007)	389	18	4.85	+	3.71	3.32E-06	3.01E-04
chondroitin sulfate proteoglycan metabolic process (GO:0050654)	45	7	.56	+	12.47	3.31E-06	3.02E-04
organonitrogen compound metabolic process (GO:1901564)	5421	102	67.60	+	1.51	3.45E-06	3.07E-04
positive regulation of cellular metabolic process (GO:0031325)	3452	73	43.04	+	1.70	3.47E-06	3.07E-04
ATP synthesis coupled electron transport (GO:0042773)	89	9	1.11	+	8.11	3.44E-06	3.08E-04
oxidative phosphorylation (GO:0006119)	119	10	1.48	+	6.74	4.60E-06	4.05E-04
positive regulation of catalytic activity (GO:0043085)	1474	40	18.38	+	2.18	4.63E-06	4.06E-04
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169)	526	21	6.56	+	3.20	4.65E-06	4.06E-04
morphogenesis of an epithelium (GO:0002009)	441	19	5.50	+	3.46	4.76E-06	4.13E-04
cellular component morphogenesis (GO:0032989)	624	23	7.78	+	2.96	5.78E-06	4.99E-04
cell part morphogenesis (GO:0032990)	536	21	6.68	+	3.14	6.15E-06	5.25E-04
head development (GO:0060322)	817	27	10.19	+	2.65	6.14E-06	5.27E-04
regulation of cellular protein metabolic process (GO:0032268)	2672	60	33.32	+	1.80	6.26E-06	5.32E-04
regulation of cell death (GO:0010941)	1707	44	21.29	+	2.07	6.57E-06	5.55E-04
response to organonitrogen compound (GO:0010243)	1011	31	12.61	+	2.46	7.08E-06	5.92E-04
regulation of peptidase activity (GO:0052547)	454	19	5.66	+	3.36	7.08E-06	5.95E-04
regulation of peptidyl-tyrosine phosphorylation (GO:0050730)	257	14	3.20	+	4.37	7.36E-06	6.12E-04
cartilage development (GO:0051216)	156	11	1.95	+	5.65	7.43E-06	6.15E-04
response to organic cyclic compound (GO:0014070)	927	29	11.56	+	2.51	7.57E-06	6.23E-04
negative regulation of signal transduction (GO:0009968)	1290	36	16.09	+	2.24	7.65E-06	6.26E-04
regulation of vascular associated smooth muscle cell proliferation (GO:1904705)	52	7	.65	+	10.80	7.83E-06	6.38E-04
regulation of growth (GO:0040008)	687	24	8.57	+	2.80	8.58E-06	6.95E-04
neuron projection morphogenesis (GO:0048812)	506	20	6.31	+	3.17	9.09E-06	7.33E-04
positive regulation of phosphorylation (GO:0042327)	1089	32	13.58	+	2.36	9.25E-06	7.38E-04
regulation of molecular function (GO:0065009)	3076	66	38.36	+	1.72	9.25E-06	7.42E-04
response to external stimulus (GO:0009605)	2526	57	31.50	+	1.81	9.50E-06	7.55E-04
positive regulation of neuron differentiation (GO:0045666)	381	17	4.75	+	3.58	9.84E-06	7.74E-04
gastrulation (GO:0007369)	161	11	2.01	+	5.48	9.84E-06	7.78E-04
endoderm development (GO:0007492)	77	8	.96	+	8.33	1.01E-05	7.90E-04
plasma membrane bounded cell projection morphogenesis (GO:0120039)	510	20	6.36	+	3.14	1.02E-05	7.91E-04
positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707)	35	6	.44	+	13.75	1.03E-05	7.96E-04
skeletal system morphogenesis (GO:0048705)	229	13	2.86	+	4.55	1.03E-05	7.99E-04
positive regulation of intracellular signal transduction (GO:1902533)	1044	31	13.02	+	2.38	1.10E-05	8.46E-04
cellular response to organonitrogen compound (GO:0071417)	604	22	7.53	+	2.92	1.11E-05	8.48E-04
cell projection morphogenesis (GO:0048858)	514	20	6.41	+	3.12	1.13E-05	8.61E-04
actin filament-based process (GO:0030029)	605	22	7.54	+	2.92	1.14E-05	8.61E-04
axon development (GO:0061564)	428	18	5.34	+	3.37	1.16E-05	8.72E-04
glycoprotein biosynthetic process (GO:0009101)	306	15	3.82	+	3.93	1.16E-05	8.72E-04
negative regulation of cell communication (GO:0010648)	1429	38	17.82	+	2.13	1.22E-05	9.13E-04
positive regulation of cell adhesion (GO:0045785)	430	18	5.36	+	3.36	1.24E-05	9.17E-04
negative regulation of signaling (GO:0023057)	1432	38	17.86	+	2.13	1.27E-05	9.39E-04
positive regulation of cell development (GO:0010720)	565	21	7.05	+	2.98	1.32E-05	9.74E-04
cell morphogenesis involved in differentiation (GO:0000904)	566	21	7.06	+	2.98	1.36E-05	9.94E-04
axonogenesis (GO:0007409)	392	17	4.89	+	3.48	1.40E-05	1.02E-03
negative regulation of response to stimulus (GO:0048585)	1837	45	22.91	+	1.96	1.46E-05	1.05E-03
mucopolysaccharide metabolic process (GO:1903510)	108	9	1.35	+	6.68	1.47E-05	1.05E-03
positive regulation of kinase activity (GO:0033674)	615	22	7.67	+	2.87	1.45E-05	1.05E-03
respiratory electron transport chain (GO:0022904)	108	9	1.35	+	6.68	1.47E-05	1.06E-03
regulation of cell morphogenesis involved in differentiation (GO:0010769)	315	15	3.93	+	3.82	1.60E-05	1.14E-03
positive regulation of neurogenesis (GO:0050769)	487	19	6.07	+	3.13	1.82E-05	1.29E-03
response to abiotic stimulus (GO:0009628)	1174	33	14.64	+	2.25	1.84E-05	1.30E-03
cellular response to oxidative stress (GO:0034599)	243	13	3.03	+	4.29	1.87E-05	1.32E-03
post-translational protein modification (GO:0043687)	361	16	4.50	+	3.55	1.95E-05	1.37E-03
cell morphogenesis (GO:0000902)	726	24	9.05	+	2.65	2.06E-05	1.43E-03
negative regulation of apoptotic process (GO:0043066)	906	28	11.30	+	2.48	2.08E-05	1.44E-03
positive regulation of cellular protein metabolic process (GO:0032270)	1620	41	20.20	+	2.03	2.08E-05	1.44E-03
localization (GO:0051179)	5845	105	72.88	+	1.44	2.10E-05	1.45E-03
regulation of vascular associated smooth muscle cell migration (GO:1904752)	23	5	.29	+	17.43	2.13E-05	1.46E-03
negative regulation of cell-substrate adhesion (GO:0010812)	62	7	.77	+	9.05	2.23E-05	1.52E-03
positive regulation of protein metabolic process (GO:0051247)	1733	43	21.61	+	1.99	2.27E-05	1.54E-03
heart morphogenesis (GO:0003007)	248	13	3.09	+	4.20	2.30E-05	1.55E-03
endodermal cell differentiation (GO:0035987)	41	6	.51	+	11.74	2.32E-05	1.56E-03
collagen metabolic process (GO:0032963)	63	7	.79	+	8.91	2.45E-05	1.64E-03
negative regulation of programmed cell death (GO:0043069)	923	28	11.51	+	2.43	2.47E-05	1.64E-03
positive regulation of epithelial cell migration (GO:0010634)	146	10	1.82	+	5.49	2.45E-05	1.64E-03
trabecula formation (GO:0060343)	24	5	.30	+	16.71	2.54E-05	1.68E-03
regulation of hydrolase activity (GO:0051336)	1297	35	16.17	+	2.16	2.55E-05	1.68E-03
embryo implantation (GO:0007566)	42	6	.52	+	11.46	2.62E-05	1.72E-03
formation of primary germ layer (GO:0001704)	117	9	1.46	+	6.17	2.67E-05	1.75E-03
chemotaxis (GO:0006935)	549	20	6.85	+	2.92	2.81E-05	1.82E-03
regulation of protein modification process (GO:0031399)	1877	45	23.41	+	1.92	2.80E-05	1.83E-03
regulation of programmed cell death (GO:0043067)	1579	40	19.69	+	2.03	2.83E-05	1.83E-03
taxis (GO:0042330)	551	20	6.87	+	2.91	2.95E-05	1.90E-03
positive regulation of nervous system development (GO:0051962)	552	20	6.88	+	2.91	3.02E-05	1.94E-03
neuron projection development (GO:0031175)	697	23	8.69	+	2.65	3.16E-05	2.01E-03
positive regulation of transferase activity (GO:0051347)	697	23	8.69	+	2.65	3.16E-05	2.02E-03
extracellular matrix disassembly (GO:0022617)	66	7	.82	+	8.51	3.23E-05	2.05E-03
response to nitrogen compound (GO:1901698)	1096	31	13.67	+	2.27	3.39E-05	2.14E-03
blood coagulation (GO:0007596)	297	14	3.70	+	3.78	3.42E-05	2.15E-03
wound healing, spreading of cells (GO:0044319)	26	5	.32	+	15.42	3.56E-05	2.21E-03
epiboly involved in wound healing (GO:0090505)	26	5	.32	+	15.42	3.56E-05	2.22E-03
regulation of catalytic activity (GO:0050790)	2392	53	29.83	+	1.78	3.56E-05	2.23E-03
bone development (GO:0060348)	187	11	2.33	+	4.72	3.65E-05	2.26E-03
coagulation (GO:0050817)	299	14	3.73	+	3.76	3.67E-05	2.26E-03
regulation of cell growth (GO:0001558)	425	17	5.30	+	3.21	3.75E-05	2.30E-03
hemostasis (GO:0007599)	302	14	3.77	+	3.72	4.07E-05	2.49E-03
response to oxygen levels (GO:0070482)	385	16	4.80	+	3.33	4.11E-05	2.50E-03
epiboly (GO:0090504)	27	5	.34	+	14.85	4.18E-05	2.54E-03
cellular response to nitrogen compound (GO:1901699)	662	22	8.25	+	2.67	4.26E-05	2.58E-03
regulation of apoptotic process (GO:0042981)	1557	39	19.41	+	2.01	4.30E-05	2.59E-03
neuron development (GO:0048666)	847	26	10.56	+	2.46	4.73E-05	2.84E-03
positive regulation of gene expression (GO:0010628)	2363	52	29.47	+	1.76	5.06E-05	3.03E-03
negative regulation of cellular component organization (GO:0051129)	723	23	9.02	+	2.55	5.44E-05	3.24E-03
actin cytoskeleton organization (GO:0030036)	530	19	6.61	+	2.87	5.50E-05	3.26E-03
negative regulation of cell differentiation (GO:0045596)	724	23	9.03	+	2.55	5.55E-05	3.28E-03
phosphorus metabolic process (GO:0006793)	2167	49	27.02	+	1.81	5.72E-05	3.37E-03
transforming growth factor beta receptor signaling pathway (GO:0007179)	100	8	1.25	+	6.42	5.79E-05	3.38E-03
integrin-mediated signaling pathway (GO:0007229)	100	8	1.25	+	6.42	5.79E-05	3.40E-03
plasma membrane bounded cell projection organization (GO:0120036)	1144	31	14.27	+	2.17	5.93E-05	3.44E-03
regeneration (GO:0031099)	163	10	2.03	+	4.92	5.92E-05	3.45E-03
cyclic nucleotide catabolic process (GO:0009214)	14	4	.17	+	22.91	6.00E-05	3.47E-03
response to lipid (GO:0033993)	871	26	10.86	+	2.39	6.11E-05	3.52E-03
regulation of cell junction assembly (GO:1901888)	199	11	2.48	+	4.43	6.23E-05	3.58E-03
regulation of MAPK cascade (GO:0043408)	732	23	9.13	+	2.52	6.52E-05	3.73E-03
positive regulation of protein kinase activity (GO:0045860)	538	19	6.71	+	2.83	6.66E-05	3.80E-03
negative regulation of protein catabolic process (GO:0042177)	133	9	1.66	+	5.43	6.82E-05	3.86E-03
cellular response to reactive oxygen species (GO:0034614)	133	9	1.66	+	5.43	6.82E-05	3.88E-03
endoderm formation (GO:0001706)	51	6	.64	+	9.43	7.06E-05	3.97E-03
regulation of actin filament organization (GO:0110053)	278	13	3.47	+	3.75	7.04E-05	3.97E-03
aging (GO:0007568)	279	13	3.48	+	3.74	7.29E-05	4.08E-03
regulation of actin cytoskeleton organization (GO:0032956)	362	15	4.51	+	3.32	7.37E-05	4.11E-03
axon guidance (GO:0007411)	280	13	3.49	+	3.72	7.54E-05	4.18E-03
dermatan sulfate proteoglycan biosynthetic process (GO:0050651)	15	4	.19	+	21.39	7.53E-05	4.19E-03
neuron projection guidance (GO:0097485)	281	13	3.50	+	3.71	7.81E-05	4.27E-03
regulation of biological quality (GO:0065008)	4085	78	50.94	+	1.53	7.80E-05	4.28E-03
heart valve morphogenesis (GO:0003179)	52	6	.65	+	9.25	7.80E-05	4.29E-03
embryonic organ development (GO:0048568)	452	17	5.64	+	3.02	7.78E-05	4.30E-03
regulation of proteolysis (GO:0030162)	742	23	9.25	+	2.49	7.95E-05	4.33E-03
response to inorganic substance (GO:0010035)	546	19	6.81	+	2.79	8.03E-05	4.36E-03
phosphate-containing compound metabolic process (GO:0006796)	2140	48	26.68	+	1.80	8.11E-05	4.39E-03
camera-type eye development (GO:0043010)	324	14	4.04	+	3.47	8.38E-05	4.52E-03
lung development (GO:0030324)	171	10	2.13	+	4.69	8.64E-05	4.64E-03
cell morphogenesis involved in neuron differentiation (GO:0048667)	457	17	5.70	+	2.98	8.85E-05	4.74E-03
regulation of body fluid levels (GO:0050878)	506	18	6.31	+	2.85	9.49E-05	5.07E-03
negative regulation of cell population proliferation (GO:0008285)	701	22	8.74	+	2.52	9.59E-05	5.10E-03
cell junction organization (GO:0034330)	507	18	6.32	+	2.85	9.72E-05	5.16E-03
cellular response to chemical stress (GO:0062197)	288	13	3.59	+	3.62	9.89E-05	5.23E-03
respiratory tube development (GO:0030323)	175	10	2.18	+	4.58	1.04E-04	5.45E-03
regulation of supramolecular fiber organization (GO:1902903)	374	15	4.66	+	3.22	1.04E-04	5.46E-03
chordate embryonic development (GO:0043009)	655	21	8.17	+	2.57	1.04E-04	5.46E-03
glycoprotein metabolic process (GO:0009100)	375	15	4.68	+	3.21	1.07E-04	5.60E-03
electron transport chain (GO:0022900)	176	10	2.19	+	4.56	1.08E-04	5.63E-03
regulation of kinase activity (GO:0043549)	912	26	11.37	+	2.29	1.09E-04	5.65E-03
positive regulation of neuron projection development (GO:0010976)	291	13	3.63	+	3.58	1.09E-04	5.66E-03
regulation of cytoskeleton organization (GO:0051493)	561	19	7.00	+	2.72	1.13E-04	5.82E-03
positive regulation of vascular associated smooth muscle cell migration (GO:1904754)	17	4	.21	+	18.87	1.14E-04	5.84E-03
dermatan sulfate proteoglycan metabolic process (GO:0050655)	17	4	.21	+	18.87	1.14E-04	5.86E-03
positive regulation of protein modification process (GO:0031401)	1243	32	15.50	+	2.06	1.17E-04	5.99E-03
cell projection organization (GO:0030030)	1191	31	14.85	+	2.09	1.36E-04	6.90E-03
regulation of vasculature development (GO:1901342)	340	14	4.24	+	3.30	1.36E-04	6.90E-03
multi-multicellular organism process (GO:0044706)	220	11	2.74	+	4.01	1.45E-04	7.34E-03
positive regulation of phospholipase activity (GO:0010518)	59	6	.74	+	8.16	1.48E-04	7.44E-03
homotypic cell-cell adhesion (GO:0034109)	59	6	.74	+	8.16	1.48E-04	7.46E-03
embryo development ending in birth or egg hatching (GO:0009792)	674	21	8.40	+	2.50	1.53E-04	7.63E-03
axon extension (GO:0048675)	37	5	.46	+	10.84	1.60E-04	7.95E-03
cell-substrate adhesion (GO:0031589)	185	10	2.31	+	4.33	1.59E-04	7.96E-03
positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068)	87	7	1.08	+	6.45	1.63E-04	8.08E-03
response to hydroperoxide (GO:0033194)	19	4	.24	+	16.88	1.66E-04	8.18E-03
regulation of cellular component biogenesis (GO:0044087)	979	27	12.21	+	2.21	1.68E-04	8.27E-03
positive regulation of cellular component organization (GO:0051130)	1213	31	15.13	+	2.05	1.72E-04	8.44E-03
heart valve development (GO:0003170)	61	6	.76	+	7.89	1.75E-04	8.53E-03
protein modification process (GO:0036211)	3176	63	39.60	+	1.59	1.75E-04	8.54E-03
cellular protein modification process (GO:0006464)	3176	63	39.60	+	1.59	1.75E-04	8.57E-03
regulation of cardiac muscle cell contraction (GO:0086004)	38	5	.47	+	10.55	1.79E-04	8.69E-03
positive regulation of hydrolase activity (GO:0051345)	770	23	9.60	+	2.40	1.80E-04	8.70E-03
positive regulation of cell projection organization (GO:0031346)	394	15	4.91	+	3.05	1.80E-04	8.70E-03
regulation of angiogenesis (GO:0045765)	307	13	3.83	+	3.40	1.81E-04	8.71E-03
regulation of epithelial cell migration (GO:0010632)	226	11	2.82	+	3.90	1.82E-04	8.72E-03
actin filament organization (GO:0007015)	267	12	3.33	+	3.60	1.90E-04	9.07E-03
energy derivation by oxidation of organic compounds (GO:0015980)	228	11	2.84	+	3.87	1.96E-04	9.29E-03
eye morphogenesis (GO:0048592)	154	9	1.92	+	4.69	1.95E-04	9.31E-03
positive regulation of transcription by RNA polymerase II (GO:0045944)	1259	32	15.70	+	2.04	1.98E-04	9.37E-03
regulation of cell-matrix adhesion (GO:0001952)	121	8	1.51	+	5.30	2.01E-04	9.49E-03
positive regulation of vasculature development (GO:1904018)	191	10	2.38	+	4.20	2.04E-04	9.61E-03
regulation of primary metabolic process (GO:0080090)	6088	104	75.91	+	1.37	2.07E-04	9.65E-03
regulation of cell-substrate junction assembly (GO:0090109)	63	6	.79	+	7.64	2.06E-04	9.66E-03
regulation of relaxation of cardiac muscle (GO:1901897)	7	3	.09	+	34.37	2.08E-04	9.67E-03
regulation of focal adhesion assembly (GO:0051893)	63	6	.79	+	7.64	2.06E-04	9.69E-03
roof of mouth development (GO:0060021)	91	7	1.13	+	6.17	2.11E-04	9.81E-03
regulation of axonogenesis (GO:0050770)	192	10	2.39	+	4.18	2.12E-04	9.82E-03
negative regulation of locomotion (GO:0040013)	313	13	3.90	+	3.33	2.17E-04	1.00E-02
protein autophosphorylation (GO:0046777)	193	10	2.41	+	4.16	2.21E-04	1.02E-02
negative regulation of cellular component movement (GO:0051271)	315	13	3.93	+	3.31	2.30E-04	1.05E-02
positive regulation of MAPK cascade (GO:0043410)	545	18	6.80	+	2.65	2.30E-04	1.06E-02
cellular respiration (GO:0045333)	158	9	1.97	+	4.57	2.34E-04	1.07E-02
positive regulation of peptidase activity (GO:0010952)	195	10	2.43	+	4.11	2.39E-04	1.09E-02
positive regulation of cell morphogenesis involved in differentiation (GO:0010770)	159	9	1.98	+	4.54	2.45E-04	1.11E-02
cyclic nucleotide metabolic process (GO:0009187)	41	5	.51	+	9.78	2.47E-04	1.12E-02
regulation of extracellular matrix organization (GO:1903053)	41	5	.51	+	9.78	2.47E-04	1.12E-02
regulation of muscle system process (GO:0090257)	235	11	2.93	+	3.75	2.51E-04	1.13E-02
regulation of phosphatidylinositol 3-kinase signaling (GO:0014066)	126	8	1.57	+	5.09	2.60E-04	1.17E-02
respiratory system development (GO:0060541)	198	10	2.47	+	4.05	2.69E-04	1.20E-02
regulation of Ras protein signal transduction (GO:0046578)	198	10	2.47	+	4.05	2.69E-04	1.20E-02
response to hyperoxia (GO:0055093)	22	4	.27	+	14.58	2.71E-04	1.21E-02
regulation of actin filament-based movement (GO:1903115)	42	5	.52	+	9.55	2.74E-04	1.22E-02
regulation of cell-substrate junction organization (GO:0150116)	67	6	.84	+	7.18	2.81E-04	1.24E-02
cardiac chamber morphogenesis (GO:0003206)	128	8	1.60	+	5.01	2.88E-04	1.27E-02
cell-matrix adhesion (GO:0007160)	128	8	1.60	+	5.01	2.88E-04	1.27E-02
negative regulation of protein metabolic process (GO:0051248)	1135	29	14.15	+	2.05	3.01E-04	1.32E-02
regulation of nitrogen compound metabolic process (GO:0051171)	5895	101	73.51	+	1.37	3.00E-04	1.32E-02
positive regulation of phospholipase C activity (GO:0010863)	43	5	.54	+	9.33	3.03E-04	1.32E-02
intracellular signal transduction (GO:0035556)	1652	38	20.60	+	1.84	3.04E-04	1.32E-02
carbohydrate derivative biosynthetic process (GO:1901137)	611	19	7.62	+	2.49	3.22E-04	1.40E-02
embryonic skeletal system morphogenesis (GO:0048704)	98	7	1.22	+	5.73	3.23E-04	1.40E-02
cell activation (GO:0001775)	1071	28	13.35	+	2.10	3.27E-04	1.40E-02
cranial skeletal system development (GO:1904888)	69	6	.86	+	6.97	3.26E-04	1.40E-02
regulation of small GTPase mediated signal transduction (GO:0051056)	327	13	4.08	+	3.19	3.26E-04	1.41E-02
platelet aggregation (GO:0070527)	44	5	.55	+	9.11	3.34E-04	1.43E-02
kidney epithelium development (GO:0072073)	131	8	1.63	+	4.90	3.34E-04	1.43E-02
response to steroid hormone (GO:0048545)	329	13	4.10	+	3.17	3.44E-04	1.47E-02
regulation of phospholipase activity (GO:0010517)	70	6	.87	+	6.87	3.50E-04	1.48E-02
cellular response to hormone stimulus (GO:0032870)	565	18	7.05	+	2.55	3.50E-04	1.49E-02
regulation of binding (GO:0051098)	375	14	4.68	+	2.99	3.57E-04	1.51E-02
atrioventricular valve morphogenesis (GO:0003181)	24	4	.30	+	13.37	3.65E-04	1.53E-02
adrenal gland development (GO:0030325)	24	4	.30	+	13.37	3.65E-04	1.54E-02
regulation of phospholipase C activity (GO:1900274)	45	5	.56	+	8.91	3.67E-04	1.54E-02
cAMP catabolic process (GO:0006198)	9	3	.11	+	26.73	3.74E-04	1.56E-02
ATP metabolic process (GO:0046034)	207	10	2.58	+	3.87	3.76E-04	1.57E-02
regulation of endopeptidase activity (GO:0052548)	425	15	5.30	+	2.83	3.92E-04	1.63E-02
cellular response to hydrogen peroxide (GO:0070301)	72	6	.90	+	6.68	4.03E-04	1.67E-02
positive regulation of lipase activity (GO:0060193)	72	6	.90	+	6.68	4.03E-04	1.67E-02
positive regulation of angiogenesis (GO:0045766)	171	9	2.13	+	4.22	4.07E-04	1.67E-02
regulation of actin filament bundle assembly (GO:0032231)	102	7	1.27	+	5.50	4.06E-04	1.68E-02
negative regulation of cell development (GO:0010721)	336	13	4.19	+	3.10	4.17E-04	1.71E-02
cell adhesion mediated by integrin (GO:0033627)	25	4	.31	+	12.83	4.19E-04	1.72E-02
cardiac chamber development (GO:0003205)	172	9	2.14	+	4.20	4.24E-04	1.73E-02
ventricular septum development (GO:0003281)	73	6	.91	+	6.59	4.32E-04	1.76E-02
regulation of cellular response to growth factor stimulus (GO:0090287)	294	12	3.67	+	3.27	4.39E-04	1.78E-02
regulation of transferase activity (GO:0051338)	1031	27	12.86	+	2.10	4.46E-04	1.81E-02
muscle system process (GO:0003012)	295	12	3.68	+	3.26	4.52E-04	1.83E-02
positive regulation of Ras protein signal transduction (GO:0046579)	74	6	.92	+	6.50	4.62E-04	1.86E-02
cardiac septum morphogenesis (GO:0060411)	74	6	.92	+	6.50	4.62E-04	1.86E-02
trabecula morphogenesis (GO:0061383)	48	5	.60	+	8.35	4.83E-04	1.91E-02
regulation of response to wounding (GO:1903034)	175	9	2.18	+	4.12	4.78E-04	1.92E-02
atrioventricular valve development (GO:0003171)	26	4	.32	+	12.34	4.79E-04	1.92E-02
receptor clustering (GO:0043113)	48	5	.60	+	8.35	4.83E-04	1.92E-02
embryonic cranial skeleton morphogenesis (GO:0048701)	48	5	.60	+	8.35	4.83E-04	1.92E-02
chondrocyte proliferation (GO:0035988)	10	3	.12	+	24.06	4.82E-04	1.92E-02
protein phosphorylation (GO:0006468)	947	25	11.81	+	2.12	4.91E-04	1.94E-02
mitochondrial electron transport, NADH to ubiquinone (GO:0006120)	49	5	.61	+	8.18	5.27E-04	2.08E-02
positive regulation of binding (GO:0051099)	178	9	2.22	+	4.05	5.37E-04	2.11E-02
positive regulation of nucleic acid-templated transcription (GO:1903508)	1694	38	21.12	+	1.80	5.49E-04	2.15E-02
positive regulation of RNA biosynthetic process (GO:1902680)	1695	38	21.14	+	1.80	5.51E-04	2.16E-02
positive regulation of developmental growth (GO:0048639)	179	9	2.23	+	4.03	5.58E-04	2.18E-02
positive regulation of nucleobase-containing compound metabolic process (GO:0045935)	1952	42	24.34	+	1.73	5.65E-04	2.20E-02
neuron recognition (GO:0008038)	50	5	.62	+	8.02	5.74E-04	2.23E-02
circulatory system process (GO:0003013)	491	16	6.12	+	2.61	5.87E-04	2.27E-02
nitrogen compound metabolic process (GO:0006807)	7114	116	88.71	+	1.31	5.99E-04	2.31E-02
morphogenesis of an epithelial sheet (GO:0002011)	51	5	.64	+	7.86	6.24E-04	2.41E-02
mesenchyme development (GO:0060485)	222	10	2.77	+	3.61	6.34E-04	2.43E-02
response to estradiol (GO:0032355)	145	8	1.81	+	4.42	6.33E-04	2.43E-02
positive regulation of transcription, DNA-templated (GO:0045893)	1600	36	19.95	+	1.80	6.32E-04	2.43E-02
negative regulation of cell projection organization (GO:0031345)	183	9	2.28	+	3.94	6.49E-04	2.48E-02
cardiac septum development (GO:0003279)	111	7	1.38	+	5.06	6.54E-04	2.49E-02
sulfur compound biosynthetic process (GO:0044272)	184	9	2.29	+	3.92	6.74E-04	2.56E-02
organ growth (GO:0035265)	80	6	1.00	+	6.01	6.80E-04	2.58E-02
carbohydrate derivative metabolic process (GO:1901135)	1011	26	12.61	+	2.06	6.87E-04	2.60E-02
positive regulation of chemotaxis (GO:0050921)	147	8	1.83	+	4.36	6.89E-04	2.60E-02
response to increased oxygen levels (GO:0036296)	29	4	.36	+	11.06	6.95E-04	2.62E-02
regulation of macromolecule metabolic process (GO:0060255)	6474	107	80.73	+	1.33	7.22E-04	2.71E-02
dermatan sulfate biosynthetic process (GO:0030208)	12	3	.15	+	20.05	7.53E-04	2.82E-02
epithelium development (GO:0060429)	1121	28	13.98	+	2.00	7.68E-04	2.85E-02
positive regulation of growth (GO:0045927)	270	11	3.37	+	3.27	7.66E-04	2.86E-02
positive regulation of small GTPase mediated signal transduction (GO:0051057)	82	6	1.02	+	5.87	7.68E-04	2.86E-02
sensory organ morphogenesis (GO:0090596)	270	11	3.37	+	3.27	7.66E-04	2.86E-02
regulation of neuron projection regeneration (GO:0070570)	30	4	.37	+	10.69	7.80E-04	2.88E-02
negative regulation of neuron apoptotic process (GO:0043524)	150	8	1.87	+	4.28	7.81E-04	2.88E-02
response to cytokine (GO:0034097)	1124	28	14.02	+	2.00	7.78E-04	2.88E-02
female pregnancy (GO:0007565)	189	9	2.36	+	3.82	8.08E-04	2.97E-02
cellular component assembly (GO:0022607)	2379	48	29.66	+	1.62	8.28E-04	3.04E-02
regulation of osteoblast differentiation (GO:0045667)	116	7	1.45	+	4.84	8.37E-04	3.07E-02
positive regulation of cell death (GO:0010942)	710	20	8.85	+	2.26	8.58E-04	3.13E-02
macromolecule metabolic process (GO:0043170)	6354	105	79.23	+	1.33	8.67E-04	3.16E-02
activation of phospholipase C activity (GO:0007202)	31	4	.39	+	10.35	8.72E-04	3.16E-02
generation of precursor metabolites and energy (GO:0006091)	412	14	5.14	+	2.73	8.70E-04	3.17E-02
positive regulation of proteolysis (GO:0045862)	365	13	4.55	+	2.86	8.76E-04	3.17E-02
negative regulation of relaxation of cardiac muscle (GO:1901898)	2	2	.02	+	80.20	8.92E-04	3.22E-02
eyelid development in camera-type eye (GO:0061029)	13	3	.16	+	18.51	9.18E-04	3.29E-02
positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568)	13	3	.16	+	18.51	9.18E-04	3.30E-02
positive regulation of ATP biosynthetic process (GO:2001171)	13	3	.16	+	18.51	9.18E-04	3.31E-02
rhythmic process (GO:0048511)	277	11	3.45	+	3.18	9.36E-04	3.35E-02
regulation of protein kinase activity (GO:0045859)	803	22	10.01	+	2.20	9.41E-04	3.36E-02
peptidyl-tyrosine modification (GO:0018212)	155	8	1.93	+	4.14	9.57E-04	3.41E-02
regulation of transforming growth factor beta receptor signaling pathway (GO:0017015)	119	7	1.48	+	4.72	9.65E-04	3.42E-02
positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731)	194	9	2.42	+	3.72	9.64E-04	3.43E-02
face morphogenesis (GO:0060325)	32	4	.40	+	10.02	9.71E-04	3.44E-02
macromolecule modification (GO:0043412)	3398	63	42.37	+	1.49	9.82E-04	3.47E-02
negative regulation of cell motility (GO:2000146)	281	11	3.50	+	3.14	1.05E-03	3.68E-02
negative regulation of cell adhesion (GO:0007162)	281	11	3.50	+	3.14	1.05E-03	3.69E-02
regulation of cellular response to transforming growth factor beta stimulus (GO:1903844)	121	7	1.51	+	4.64	1.06E-03	3.71E-02
regulation of calcium ion transmembrane transport (GO:1903169)	158	8	1.97	+	4.06	1.08E-03	3.77E-02
response to alcohol (GO:0097305)	239	10	2.98	+	3.36	1.09E-03	3.78E-02
localization within membrane (GO:0051668)	88	6	1.10	+	5.47	1.09E-03	3.78E-02
response to vitamin (GO:0033273)	88	6	1.10	+	5.47	1.09E-03	3.79E-02
regulation of ossification (GO:0030278)	198	9	2.47	+	3.65	1.11E-03	3.81E-02
dermatan sulfate metabolic process (GO:0030205)	14	3	.17	+	17.18	1.11E-03	3.82E-02
regulation of relaxation of muscle (GO:1901077)	14	3	.17	+	17.18	1.11E-03	3.83E-02
regulation of extracellular matrix assembly (GO:1901201)	14	3	.17	+	17.18	1.11E-03	3.84E-02
cell junction assembly (GO:0034329)	284	11	3.54	+	3.11	1.14E-03	3.91E-02
positive regulation of axonogenesis (GO:0050772)	89	6	1.11	+	5.41	1.15E-03	3.93E-02
positive regulation of ossification (GO:0045778)	89	6	1.11	+	5.41	1.15E-03	3.94E-02
transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178)	200	9	2.49	+	3.61	1.18E-03	4.04E-02
regulation of metabolic process (GO:0019222)	7021	113	87.55	+	1.29	1.19E-03	4.06E-02
positive regulation of RNA metabolic process (GO:0051254)	1784	38	22.25	+	1.71	1.20E-03	4.06E-02
purine ribonucleotide catabolic process (GO:0009154)	34	4	.42	+	9.43	1.19E-03	4.06E-02
regulation of stress fiber assembly (GO:0051492)	90	6	1.12	+	5.35	1.21E-03	4.10E-02
negative regulation of response to wounding (GO:1903035)	90	6	1.12	+	5.35	1.21E-03	4.10E-02
regulation of protein-containing complex disassembly (GO:0043244)	126	7	1.57	+	4.46	1.32E-03	4.42E-02
positive regulation of endothelial cell chemotaxis (GO:2001028)	15	3	.19	+	16.04	1.31E-03	4.43E-02
ribonucleotide catabolic process (GO:0009261)	35	4	.44	+	9.17	1.32E-03	4.43E-02
neuron migration (GO:0001764)	126	7	1.57	+	4.46	1.32E-03	4.43E-02
heart trabecula formation (GO:0060347)	15	3	.19	+	16.04	1.31E-03	4.44E-02
developmental cell growth (GO:0048588)	92	6	1.15	+	5.23	1.35E-03	4.48E-02
regulation of protein depolymerization (GO:1901879)	92	6	1.15	+	5.23	1.35E-03	4.49E-02
mesonephros development (GO:0001823)	92	6	1.15	+	5.23	1.35E-03	4.50E-02
brain development (GO:0007420)	772	21	9.63	+	2.18	1.37E-03	4.54E-02
regulation of muscle contraction (GO:0006937)	165	8	2.06	+	3.89	1.40E-03	4.64E-02
muscle structure development (GO:0061061)	485	15	6.05	+	2.48	1.43E-03	4.73E-02
embryonic appendage morphogenesis (GO:0035113)	128	7	1.60	+	4.39	1.44E-03	4.74E-02
embryonic limb morphogenesis (GO:0030326)	128	7	1.60	+	4.39	1.44E-03	4.75E-02
positive regulation of G1/S transition of mitotic cell cycle (GO:1900087)	36	4	.45	+	8.91	1.45E-03	4.75E-02
platelet-derived growth factor receptor signaling pathway (GO:0048008)	36	4	.45	+	8.91	1.45E-03	4.76E-02
apoptotic process involved in luteolysis (GO:0061364)	3	2	.04	+	53.46	1.47E-03	4.77E-02
regulation of substrate-dependent cell migration, cell attachment to substrate (GO:1904235)	3	2	.04	+	53.46	1.47E-03	4.78E-02
positive regulation of substrate-dependent cell migration, cell attachment to substrate (GO:1904237)	3	2	.04	+	53.46	1.47E-03	4.79E-02
membrane depolarization during atrial cardiac muscle cell action potential (GO:0098912)	3	2	.04	+	53.46	1.47E-03	4.80E-02
negative regulation of transforming growth factor-beta secretion (GO:2001202)	3	2	.04	+	53.46	1.47E-03	4.81E-02
negative regulation of endodermal cell differentiation (GO:1903225)	3	2	.04	+	53.46	1.47E-03	4.82E-02
cell growth (GO:0016049)	94	6	1.17	+	5.12	1.49E-03	4.83E-02
regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092)	251	10	3.13	+	3.20	1.55E-03	4.98E-02
